Derek Murphy
YOU?
Author Swipe
View article: Physical activity and temperature changes of Asian elephants (Elephas maximus) participating in eco-tourism activities and elephant polo
Physical activity and temperature changes of Asian elephants (Elephas maximus) participating in eco-tourism activities and elephant polo Open
Captive and domestic animals are often required to engage in physical activity initiated or organised by humans, which may impact their body temperature, with consequences for their health and welfare. This is a particular concern for anim…
View article: Supplementary Table 3 from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade
Supplementary Table 3 from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade Open
Comparison of Microsatellite Status Determined through FFPE Tissue Analyses
View article: Supplementary Table 3 from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade
Supplementary Table 3 from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade Open
Comparison of Microsatellite Status Determined through FFPE Tissue Analyses
View article: Supplementary Table 2 from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade
Supplementary Table 2 from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade Open
Summary of Next Generation Sequencing Statistics for FFPE Tumor and Matched Normal Samples
View article: Supplementary Figure 1 from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade
Supplementary Figure 1 from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade Open
Archival Tissue-Based Detection of Microsatellite Instability and High Tumor Mutation Burden.
View article: Supplementary Data from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade
Supplementary Data from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade Open
Radiographic Imaging of Case CS98 Displaying a Complete Response to Immune Checkpoint Blockade.
View article: Supplementary Table 8 from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade
Supplementary Table 8 from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade Open
Comparison of Tumor Mutation Burden and Microsatellite Status for Patients Evaluated for Response to Immune Checkpoint Blockade
View article: Supplementary Table 1 from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade
Supplementary Table 1 from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade Open
125 Gene List for FFPE Tissue Analyses
View article: Supplementary Figure 3 from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade
Supplementary Figure 3 from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade Open
Plasma-Based Progression Free Survival Analysis for Patients Treated with Immune Checkpoint Blockade.
View article: Supplementary Table 2 from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade
Supplementary Table 2 from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade Open
Summary of Next Generation Sequencing Statistics for FFPE Tumor and Matched Normal Samples
View article: Supplementary Figure 1 from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade
Supplementary Figure 1 from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade Open
Archival Tissue-Based Detection of Microsatellite Instability and High Tumor Mutation Burden.
View article: Data from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade
Data from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade Open
Purpose:Microsatellite instability (MSI) and high tumor mutation burden (TMB-High) are promising pan-tumor biomarkers used to select patients for treatment with immune checkpoint blockade; however, real-time sequencing of unresectable or m…
View article: Data from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade
Data from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade Open
Purpose:Microsatellite instability (MSI) and high tumor mutation burden (TMB-High) are promising pan-tumor biomarkers used to select patients for treatment with immune checkpoint blockade; however, real-time sequencing of unresectable or m…
View article: Supplementary Figure 2 from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade
Supplementary Figure 2 from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade Open
Plasma-Based Detection of Microsatellite Instability and High Tumor Mutation Burden in Patients with Sufficient Circulating Tumor DNA.
View article: Supplementary Data from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade
Supplementary Data from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade Open
Schematic of the Digital Peak Finding Bioinformatics Approach to Detect Microsatellite Instability in Circulating Tumor DNA from Plasma.
View article: Supplementary Figure 3 from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade
Supplementary Figure 3 from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade Open
Plasma-Based Progression Free Survival Analysis for Patients Treated with Immune Checkpoint Blockade.
View article: Supplementary Table 4 from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade
Supplementary Table 4 from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade Open
58 Gene List for Plasma Analyses
View article: Supplementary Data from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade
Supplementary Data from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade Open
Schematic of the Digital Peak Finding Bioinformatics Approach to Detect Microsatellite Instability in Circulating Tumor DNA from Plasma.
View article: Supplementary Table 6 from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade
Supplementary Table 6 from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade Open
Comparison of Microsatellite Status Determined through Healthy Donor, Contrived, and Clinical Plasma Analyses
View article: Supplementary Table 8 from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade
Supplementary Table 8 from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade Open
Comparison of Tumor Mutation Burden and Microsatellite Status for Patients Evaluated for Response to Immune Checkpoint Blockade
View article: Supplementary Table 1 from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade
Supplementary Table 1 from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade Open
125 Gene List for FFPE Tissue Analyses
View article: Supplementary Table 5 from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade
Supplementary Table 5 from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade Open
Summary of Next Generation Sequencing Statistics for Healthy Donor Samples, Contrived Samples, and Clinical Plasma Samples
View article: Supplementary Data from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade
Supplementary Data from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade Open
Radiographic Imaging of Case CS98 Displaying a Complete Response to Immune Checkpoint Blockade.
View article: Supplementary Table 7 from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade
Supplementary Table 7 from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade Open
Summary of Clinical Information for 16 Patients Evaluated for Response to Immune Checkpoint Blockade
View article: Supplementary Figure 2 from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade
Supplementary Figure 2 from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade Open
Plasma-Based Detection of Microsatellite Instability and High Tumor Mutation Burden in Patients with Sufficient Circulating Tumor DNA.
View article: Supplementary Table 6 from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade
Supplementary Table 6 from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade Open
Comparison of Microsatellite Status Determined through Healthy Donor, Contrived, and Clinical Plasma Analyses
View article: Supplementary Table 4 from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade
Supplementary Table 4 from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade Open
58 Gene List for Plasma Analyses
View article: Supplementary Table 7 from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade
Supplementary Table 7 from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade Open
Summary of Clinical Information for 16 Patients Evaluated for Response to Immune Checkpoint Blockade
View article: Supplementary Table 5 from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade
Supplementary Table 5 from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade Open
Summary of Next Generation Sequencing Statistics for Healthy Donor Samples, Contrived Samples, and Clinical Plasma Samples
View article: Supplementary Figure 3 from MicroRNA Mediates DNA Demethylation Events Triggered by Retinoic Acid during Neuroblastoma Cell Differentiation
Supplementary Figure 3 from MicroRNA Mediates DNA Demethylation Events Triggered by Retinoic Acid during Neuroblastoma Cell Differentiation Open
Supplementary Figure 3 from MicroRNA Mediates DNA Demethylation Events Triggered by Retinoic Acid during Neuroblastoma Cell Differentiation